| Harold V Stewart, MD | |
|
2930 Maple St, Everett, WA 98201-3832 | |
| (425) 261-1500 | |
| Not Available |
| Full Name | Harold V Stewart |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 2930 Maple St, Everett, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467675884 | NPI | - | NPPES |
| 217817 | Other | WA | L&I |
| 8538654 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | MD00020758 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harold V Stewart, MD Po Box 34581, Seattle, WA 98124-1581 Ph: (509) 241-7349 | Harold V Stewart, MD 2930 Maple St, Everett, WA 98201-3832 Ph: (425) 261-1500 |
News Archive
Endo International plc announced today that affiliates of the company have completed the acquisition of worldwide rights to Sumavel® DosePro® (sumatriptan injection), a needle-free delivery system for subcutaneous use, from Zogenix, Inc, for $85 million in cash and rights to additional cash payments based on the achievement of certain commercial milestones.
Older adults who have hip or knee replacement surgery for severe osteoarthritis may take several weeks to recover but appear to have excellent long-term outcomes, according to a report in the July 14 issue of Archives of Internal Medicine.
Stevens Institute of Technology has signed an exclusive licensing agreement with Bonbouton, giving the cutting-edge health and technology company the right to use and further develop a graphene sensing system that detects early signs of foot ulcers before they form so people living with diabetes can access preventative healthcare and confidently manage their health.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
In a surprising move, the Obama administration will extend special bonus payments meant to reward top-performing Medicare Advantage insurers to those that score only average ratings.
› Verified 7 days ago
Dr. Christopher Gareth Hardy, D.O. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4027 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5489 Fax: 425-317-3689 | |
Jiho C Bryson, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4027 Hoyt Ave Ste 104, Everett, WA 98201 Phone: 425-339-5489 | |
Dr. Mark Edward Beatty, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3020 Rucker Ave Ste 306, Everett, WA 98201 Phone: 425-339-8799 Fax: 425-339-5263 | |
Dr. Vanessa Nicholson, M. D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 12800 Bothell Everett Hwy, Everett, WA 98208 Phone: 425-316-5150 Fax: 425-225-1006 | |
Dr. James R Enright, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-258-3903 Fax: 425-339-4238 |